Renal function decline and heart failure hospitalisation in patients with type 2 diabetes: Dynamic predictions from the prospective SURDIAGENE cohort.


Journal

Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 21 06 2022
revised: 27 10 2022
accepted: 06 11 2022
pubmed: 15 11 2022
medline: 15 12 2022
entrez: 14 11 2022
Statut: ppublish

Résumé

For type 2 diabetes persons, we assessed the association between renal function decline and heart failure hospitalisation (HFH) and validated dynamic HFH predictions (DynHFH) based on repeated estimated Glomerular Filtration Rate (eGFR) values. We studied 1413 patients from the SURDIAGENE cohort. From a joint model for longitudinal CKD-EPI measures and HFH risk, we calculated the probability of being HFH-free in the next five years. The mean eGFR decline was estimated at 1.48 ml/min/1.73 m Renal function decline was significantly associated with the HFH risk. In the era of computer-assisted medical decisions, the DynHFH, a tool that dynamically predicts HFH in type 2 diabetes persons (https://shiny.idbc.fr/DynHFH), might be helpful for precision medicine and the implementation of stratified medical decision-making.

Identifiants

pubmed: 36375567
pii: S0168-8227(22)00966-4
doi: 10.1016/j.diabres.2022.110152
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110152

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Etienne Dantan (E)

Nantes Université, Univ Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000 Nantes, France. Electronic address: Etienne.Dantan@univ-nantes.fr.

Maxime Pailler (M)

Nantes Université, Univ Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000 Nantes, France.

Stéphanie Ragot (S)

Université de Poitiers, CHU de Poitiers, INSERM, Centre d'Investigation Clinique CIC 1402, Poitiers, France.

Elise Gand (E)

Université de Poitiers, CHU de Poitiers, INSERM, Centre d'Investigation Clinique CIC 1402, Poitiers, France.

Jean-Noel Trochu (JN)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Bertrand Cariou (B)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Pierre-Jean Saulnier (PJ)

Université de Poitiers, CHU de Poitiers, INSERM, Centre d'Investigation Clinique CIC 1402, Poitiers, France.

Samy Hadjadj (S)

Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH